We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
-1.7%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.94B
AUM Growth
-$132M
(-4.3%)
Cap. Flow
-$33.9M
Cap. Flow
% of AUM
-1.15%
Top 10 Holdings %
Top 10 Hldgs %
52.45%
Holding
59
New
22
Increased
10
Reduced
13
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$169M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$104M |
| 3 |
Zimmer Biomet
ZBH
|
+$95.7M |
| 4 |
Agilent Technologies
A
|
+$73.9M |
| 5 |
UnitedHealth
UNH
|
+$69.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$202M |
| 2 |
Medtronic
MDT
|
+$151M |
| 3 |
Incyte
INCY
|
+$110M |
| 4 |
CELG
Celgene Corp
CELG
|
+$100M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sarepta Therapeutics
SRPT
$1.7B
| – | – |
-1,309,960
| Closed | -$72.9M |
|
52
Stryker
SYK
$129B
| – | – |
-166,280
| Closed | -$25.7M |
|
53
Tenet Healthcare
THC
$21.1B
| – | – |
-2,956,351
| Closed | -$44.8M |
|
|
54
CALL
Zimmer Biomet
ZBH
$18.9B
| – | – |
-103,000
| Closed | -$12.1M |
|
55
Zoetis
ZTS
$31.1B
| – | – |
-645,100
| Closed | -$46.5M |
|
|
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-973,840
| Closed | -$66.2M |
|
|
FPRX
57
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-101,000
| Closed | -$2.21M |
|
|
MNK
58
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-284,400
| Closed | -$6.42M |
|
|
BIVV
59
DELISTED
Bioverativ Inc. Common Stock
BIVV
| – | – |
-3,750,000
| Closed | -$202M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q1 2018 Portfolio in Review
As of Q1 2018, HealthCor Management held 59 positions worth $2.94B, down 4.3% from $3.07B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
HealthCor Management's Q1 2018 filing shows 22 new, 10 increased, 13 reduced and 13 closed positions. Its largest new stake was Dentsply Sirona: 2,875,000 shares worth $145M. The largest sale was Bioverativ Inc. Common Stock, an estimated $202M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 100% a quarter earlier.
- HealthCor Management's largest Q1 2018 buy was Dentsply Sirona: 2,875,000 shares worth $145M.
- HealthCor Management added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $104M increase.
- HealthCor Management's biggest Q1 2018 reduction was Medtronic, cutting an estimated $151M.
- HealthCor Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $202M.
- HealthCor Management's ten largest holdings make up 52% of its $2.94B portfolio in Q1 2018.
- HealthCor Management opened 22 new positions and closed 13 in Q1 2018.
- HealthCor Management's portfolio value fell 4.3% quarter-over-quarter to $2.94B.
Based on HealthCor Management's 13F filing for Q1 2018, filed 15 May 2018.